NitroMed Home
NitroMed Pipeline Technology News: Press Releases Investors Careers
About Heart Failure

BiDil
- A-HeFT
- A-HeFT Extension

Next Generation BiDil

BiDil Cost Effectiveness

Genomic Analyses

BiDil Publications

BiDil® PUBLICATIONS

Angus, D.C., Linde-Zwirble, W.C., Tam, S,W., Ghali, J.K, Sabolinski, M.L.,Villagra,V.G., Winkelmayer, W.C., Worcel, M.  Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks with Heart Failure.  Circulation 112: 3745-3753 (2005)

Taylor, A.L., Ziesche, S., Yancy, C., Carson, P., D’Agostino, R. Jr., , Ferdinand, K, Taylor, M., Adams, K., Sabolinski, M., Worcel, M., Cohn, J.N. and the A-HeFT Investigators. Combination of Isosorbide Dinitrate and Hydralazine in African Americans with Heart Failure. N. Engl. J. Med., 351: 2049-2057 (2004)

Taylor, A.L., Cohn, J.N., Worcel, M., Franciosa, J.A.  A-HeFT Investigators, African-American Heart Failure Trial. The African-American Heart Failure Trial: background, rationale and significance. J Natl. Med. Assoc. 94: 762-769 (2002)
 
NitroMed | BiDil | Technology | News | Investors | Careers
Privacy Policy | Legal Notice | MSDS
Copyright © 2007 NitroMed, Inc. All Rights Reserved.
Contact Site Map Media Center Home